Home
Håvard Søiland's picture

Håvard Søiland

Professor
  • E-mailHavard.Soiland@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Journal articles
  • Guldvog, Ivar; Reitsma, Laurens Cornelus; Johnsen, Lene Cathrin; Lauzike, Andromeda; Gibbs, Charlotte Christine; Carlsen, Eivind; Lende, Tone Hoel; Narvestad, Jon; Omdal, Roald; Kvaløy, Jan Terje; Hoff, Geir; Bernklev, Tomm; Søiland, Håvard. 2019. Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial. Annals of Internal Medicine. 170: 453-464. doi: 10.7326/M18-0284
  • Hagen, Kari Britt; Aas, Turid; Kvaløy, Jan Terje; Søiland, Håvard; Lind, Ragna Anne. 2019. Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study. Breast. 44: 52-58. doi: 10.1016/j.breast.2019.01.003
  • Helland, Thomas; Hagen, Kari Britt; Haugstøyl, Martha Eimstad; Kvaløy, Jan Terje; Lunde, Siri; Lode, Kirsten; Lind, Ragna Anne; Gripsrud, Birgitta Haga; Jonsdottir, Kristin; Gjerde, Jennifer; Bifulco, Ersilia; Hustad, Simon Steinar; Jonassen, Janne; Aas, Turid; Lende, Tone Hoel; Lien, Ernst Asbjørn; Janssen, Emiel; Søiland, Håvard; Mellgren, Gunnar. 2019. Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. Breast Cancer Research and Treatment. 177: 185-195. doi: 10.1007/s10549-019-05294-w
  • Hagen, Kari Britt; Aas, Turid; Kvaløy, Jan Terje; Søiland, Håvard; Lind, Ragna Anne. 2018. Diet in women with breast cancer compared to healthy controls - What is the difference? European Journal of Oncology Nursing. 32: 20-24. doi: 10.1016/j.ejon.2017.11.003
  • Helland, Thomas; Henne, Nina; Bifulco, Ersilia; Naume, Bjørn; Borgen, Elin; Kristensen, Vessela N.; Kvaløy, Jan Terje; Lash, Timothy L; Grenaker, Grethe Irene; van Schaik, RHN; Janssen, Emiel; Hustad, Simon Steinar; Lien, Ernst Asbjørn; Mellgren, Gunnar; Søiland, Håvard. 2017. Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients. Breast Cancer Research. 19. doi: 10.1186/s13058-017-0916-4
  • Klebaner, Daniella; Hamilton-Dutoit, Stephen; Ahern, Thomas; Crawford, Anatasha; Jakobsen, Thomas; Cronin-Fenton, Deirdre P.; Damkier, Per; Janssen, Emiel; Kjærsgaard, Anders; Ording, Anne Gulbech; Søiland, Håvard; Sørensen, Henrik Toft; Lash, Timothy L.; Hellberg, Ylva. 2017. Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifentreated patients. PLOS ONE. 12:e0171453: 1-12. doi: 10.1371/journal.pone.0171453
  • Solbrække, Kari Nyheim; Søiland, Håvard; Lode, Kirsten; Gripsrud, Birgitta Haga. 2017. Our genes, our selves: hereditary breast cancer and biological citizenship in Norway. Medicine, Health care and Philosophy. 20: 89-103. doi: 10.1007/s11019-016-9737-y
  • Gripsrud, Birgitta Haga; Brassil, Kelly J; Summers, Barbara; Søiland, Håvard; Kronowitz, Steven; Lode, Kirsten. 2016. Capturing the experience: Reflections of women with breast cancer engaged in an expressive writing intervention. Cancer Nursing. 39: E51-E60. doi: 10.1097/NCC.0000000000000300
  • Hagen, Kari Britt; Aas, Turid; Kvaløy, Jan Terje; Eriksen, Hege Randi; Søiland, Håvard; Lind, Ragna Anne. 2016. Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls. Breast. 28: 100-106. doi: 10.1016/j.breast.2016.05.005
  • Egeland, Nina Gran; Lunde, Siri; Jonsdottir, Kristin; Lende, Tone Hoel; Cronin-Fenton, Deirdre P.; Gilje, Bjørnar; Janssen, Emilius Adrianus Maria; Søiland, Håvard. 2015. The role of microRNAs as predictors of response to tamoxifen treatment in breast cancer patients. International Journal of Molecular Sciences. 16: 24243-24275. doi: 10.3390/ijms161024243
  • Helland, Thomas; Gjerde, Jennifer; Dankel, Simon N; Fenne, Ingvild Sveinsgjerd; Skartveit, Linn; Drangevåg, Andreas; Bozickovic, Olivera; Flågeng, Marianne Hauglid; Søiland, Håvard; Mellgren, Gunnar; Lien, Ernst Asbjørn. 2015. The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells. PLOS ONE. 10. 19 pages. doi: 10.1371/journal.pone.0122339
  • Gripsrud, Birgitta Haga; Søiland, Håvard; Lode, Kirsten. 2014. Ekspressiv skriving som egenterapeutisk verktøy ett år etter brystkreftdiagnosen - resultater fra en beskrivende pilotstudie. Nordisk tidsskrift for helseforskning. 10: 45-61.
  • Hagen, Kari Britt; Aas, Turid; Lode, Kirsten; Gjerde, Jennifer; Lien, Ernst Asbjørn; Kvaløy, Jan Terje; Lash, Timothy L; Søiland, Håvard; Lind, Ragna Anne. 2014. Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale. European Journal of Oncology Nursing. 1-7. doi: 10.1016/j.ejon.2014.10.009
  • Lien, Ernst Asbjørn; Søiland, Håvard; Gjerde, Jennifer. 2013. Associations between tamoxifen and age during steady state tamoxifen treatment of postmenopausal women with breast cancer. Experimental and clinical endocrinology & diabetes. 121. 1 pages. doi: 10.1055/s-0033-1336763
  • Lien, Ernst Asbjørn; Søiland, Håvard; Lundgren, Steinar; Aas, Turid; Steen, Vidar Martin; Mellgren, Gunnar; Gjerde, Jennifer. 2013. Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment. Breast Cancer Research and Treatment. 141: 243-248. doi: 10.1007/s10549-013-2677-9
  • Søiland, Håvard; Hagen, Kari Britt; Gjerde, Jennifer; Lende, Tone Hoel; Lien, Ernst Asbjørn. 2013. Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients. Acta Oncologica. 52: 861-U216. doi: 10.3109/0284186X.2012.742963
  • Lode, Kirsten; Søiland, Håvard; Gripsrud, Birgitta Haga. 2012. Å ta beslutningen sammen med pasienten. Tidsskriftet sykepleien. 6: 70-73. doi: 10.4220/sykepleiens.2012.0060
  • Søiland, Håvard; Lende, Tone Hoel; Brauckhoff, Michael. 2012. Klasiske biomarkører vs, nye molkylærbiologiske tester i prognose og prediksjon ved ajuvant behandling av brystkreft. Kirurgen. 3. 166-171.
  • Ahern, Thomas P.; Christensen, Mariann; Cronin-Fenton, Deirdre P.; Lunetta, Kathryn L.; Søiland, Håvard; Gjerde, Jennifer; Garne, Jens Peter; Rosenberg, Carol L.; Silliman, Rebecca A.; Sørensen, Henrik Toft; Lash, Timothy L.; Hamilton-Dutoit, Stephen. 2011. Functional polymorphisms in UDP-glucuronosyltransferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiology, Biomarkers and Prevention. 20: 1937-1943. Published 2011-07-12. doi: 10.1158/1055-9965.EPI-11-0419
  • Gilje, Bjørnar; Nordgård, Oddmund; Tjensvoll, Kjersti; Janssen, Emilius Adrianus Maria; Søiland, Håvard; Smaaland, Rune; Baak, Jan P.A. 2011. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients. Breast Cancer Research and Treatment. 128: 137-146. doi: 10.1007/s10549-011-1487-1
  • Gudlaugsson, Einar; Skaland, Ivar; Undersrud, Erling Sandøy; Janssen, Emilius Adrianus Maria; Søiland, Håvard; Baak, Jan P.A. 2011. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients. Modern Pathology. 24: 502-511. doi: 10.1038/modpathol.2010.199
  • Lende, Tone Hoel; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Voorhorst, Feja; Smaaland, Rune; van Diest, Paul J; Søiland, Håvard; Baak, Jan P.A. 2011. In patients younger than age 55 years with lymph node–negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant! Journal of Clinical Oncology. 29: 852-858. doi: 10.1200/JCO.2009.25.0407
  • Zhang, Hui; Slewa, Aida; Janssen, Emilius Adrianus Maria; Skaland, Ivar; Yu, Yinhua; Gudlaugsson, Einar; Feng, Weiwei; Kjellevold, Kjell H; Søiland, Håvard; Baak, Jan P.A. 2011. The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer. Anticancer Research. 31: 443-449.
  • Gudlaugsson, Einar; Skaaland, I.; Janssen, Emilius Adrianus Maria; Søiland, Håvard; Malpica, A.; Baak, Jan P.A. 2010. Comparing the prognostic value of proliferation markers Ki67, mitotic activity index, phosphohistone-3 and classical variables in breast cancer. Virchows Archiv. 457: 170-170.
  • Gudlaugsson, Einar; Skaland, Ivar; Janssen, Emilius Adrianus Maria; Smaaland, Rune; Søiland, Håvard; Baak, Jan P.A. 2010. In operable node negative breast cancer patients under 71 years, lymph vessel invasion has no additional prognostic value to PhosphoHistone-3 proliferative activity. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 118: 250-250.
  • Janssen, Emilius Adrianus Maria; Slewa, Aida; Gudlaugsson, Einar; Jonsdottir, Kristin; Skaland, Ivar; Søiland, Håvard; Baak, Jan P.A. 2010. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Modern Pathology. 23: 1567-1576. doi: 10.1038/modpathol.2010.177
  • Baak, Jan P.A.; Gudlaugsson, Einar; Skaland, Ivar; Guo, Lydia Hui Ru; Klos, Jan; Lende, Tone Hoel; Søiland, Håvard; Janssen, Emilius Adrianus Maria; Hausen, Axel zur. 2009. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Research and Treatment. 115: 241-254. doi: 10.1007/s10549-008-0126-y
  • Janssen, Emilius Adrianus Maria; Øvestad, Irene Tveiterås; Skaland, Ivar; Søiland, Håvard; Gudlaugsson, Einar; Kjellevold, Kjell-Henning; Nysted, Arne; Søreide, Jon Arne; Baak, Jan P.A. 2009. LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer. Cellular Oncology. 31: 335-343. doi: 10.3233/CLO-2009-0479
  • Lende, Tone Hoel; Gudlaugsson, Einar; Janssen, BAM; Voorhorst, F; van Diest, PJ; Søiland, Håvard; Baak, Jan P.A. 2009. Use of Receiver Operating Characteristic (ROC) Analysis To Determine the Most Optimal Prognostic Threshold for Adjuvant! in Lymph Node Negative Breast Cancer Patients < 55 Years. Cancer Research. 69: 704S-705S.
  • Lende, Tone Hoel; Gudlaugsson, Einar; Janssen, Emilius Adrianus Maria; Voorhorst, F; van Diest, PJ; Søiland, Håvard; Baak, Jan P.A. 2009. Mitotic Activity Index Identifies Both Over- and Undertreated Lymph Node Negative Breast Cancer Patients < 55 Year According to the Norwegian Treatment Guidelines. Cancer Research. 69: 706S-706S.
  • Li, Heng; Shen, Xueyong; Ying, Jian; Zhao, Ling; Jin, Mingzi; Thu, Shengfang; Sun, Chenping; Voorhorst, Eeja; Søiland, Håvard; Lende, Tone; Baak, Jan P.A. 2009. Patients with Clinical/Radiological Hyperplasia of Mammary Glands Show Pathological Presistence of Temperature of Skin Points. Anticancer Research. 29: 4697-4702.
  • Skaland, Ivar; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Klos, Jan; Kjellevold, Kjell-Henning; Søiland, Håvard; Baak, Jan P.A. 2009. Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age. Breast Cancer Research and Treatment. 114: 39-45. doi: 10.1007/s10549-008-9980-x
  • Søiland, Håvard; Janssen, Emilius Adrianus Maria; Kørner, Hartwig; Varhaug, Jan Erik; Skaland, Ivar; Gudlaugsson, Einar; Baak, Jan P.A.; Søreide, Jon Arne. 2009. Apolipoprotein D predicts adverse outcome in women a parts per thousand yen70 years with operable breast cancer. Breast Cancer Research and Treatment. 113: 519-528. doi: 10.1007/s10549-008-9955-y
  • Søiland, Håvard; Skaland, Ivar; Varhaug, Jan Erik; Kørner, Hartwig; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Baak, Jan P.A.; Søreide, Jon Arne. 2009. Co-expression of estrogen receptor agr and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncologica. 48: 514-521. doi: 10.1080/02841860802620613
  • Søiland, Håvard; Kørner, Hartwig; Skaland, Ivar; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Varhaug, Jan Erik; Baak, Jan P.A.; Søreide, Jon Arne. 2008. Prognostic Relevance of Androgen Receptor Detection in Operable Breast Cancer. Journal of Surgical Oncology. 98: 551-558. doi: 10.1002/jso.21156
  • Søiland, Håvard; Skaland, Ivar; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Kørner, Hartwig; Varhaug, Jan Erik; Søreide, Jon Arne; Baak, Jan P.A. 2008. Comparison of Apolipoprotein D determination methods in breast cancer. Anticancer Research. 28: 1151-1160.
  • Søiland, Håvard; Skaland, Ivar; Van Diermen, Bianca; Janssen, Emilius Adrianus Maria; Kørner, Hartwig; Varhaug, Jan Erik; Søreide, Jon Arne; Baak, Jan P.A. 2008. Androgen receptor determination in breast cancer - A comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis. Applied immunohistochemistry & molecular morphology (Print). 16: 362-370. doi: 10.1097/PAI.0b013e31815b9c92
  • Janssen, Emiel A.M.; Søiland, Håvard; Skaland, Ivar; Gudlaugson, Einar; Kjellevold, Kjell-Henning; Nysted, Arne; Søreide, Jon Arne; Baak, Johannes Peter A. 2007. Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged > 55 years. Cellular Oncology. 29: 25-35.
  • Janssen, Emilius Adrianus Maria; Øvestad, Irene T.; Skaland, Ivar; Søiland, Håvard; Gudlaugson, Einar; Kjellevold, Kjell-Henning; Nysted, Arne; Søreide, Jon Arne; Baak, Jan P.A. 2007. ARHI (DIRAS3) and proliferation in lymph node negative breast cancer. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 115: 1318-1318.
  • Skaland, Ivar; Janssen, Emiel A.M.; Gudlaugsson, Einar; Klos, Jan; Kjellevold, Kjell-Henning; Søiland, Håvard; Baak, Jan P.A. 2007. Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age. Modern Pathology. 20: 1307-1315. doi: 10.1038/modpathol.3800972
  • Skaland, Ivar; van Diest, Paul J; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Søiland, Håvard; Baak, Jan P.A. 2007. Prognostic differences of WHO-assessed mitotic activity index (MAI) and mitotic impression by quick scanning in invasive ductal breast cancer patients under 55 years of age. Breast Cancer Research and Treatment. 106: S60-S61.
  • Søiland, Håvard; Janssen, Emilius Adrianus Maria; Skaland, Ivar; Gudlaugsson, Einar; Kørner, Hartwig; Varhaug, Jan Erik; Søreide, Jon Arne; Baak, Jan P.A. 2007. Tissue microarray and whole sections in small sized study populations for ER-alpha, PR, HER-2 and AR in operable breast cancer: correlation and relevance for prognostication. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 115: 1314-1314.
  • Søiland, Håvard; Skaland, Ivar; Van Diermen, Bianca; Janssen, Emilius Adrianus Maria; Kørner, Hartwig; Varhaug, Jan Erik; Søreide, Jon Arne; Baak, Jan P.A. 2007. Androgen receptor determination in breast cancer: a comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis. Breast Cancer Research and Treatment. 106: S216-S216.
  • Søiland, Håvard; Søreide, Kjetil; Janssen, Emiel A.M.; Kørner, Hartwig; Baak, Jan P.A.; Søreide, Jon Arne. 2007. Emerging concepts of apolipoprotein D with possible implications for breast cancer. Cellular Oncology. 29: 195-209.
  • Søreide, K.; Søiland, H.; Lossius, Hans Morten; Vetrhus, M.; Søreide, JA; Søreide, Eldar. 2007. Resuscitative emergency thoracotomy in a Scandinavian trauma hospital - is it justified? Injury. 38.
  • Søreide, Kjetil; Søiland, Håvard; Lossius, Hans Morten; Vetrhus, Morten; Søreide, Jon Arne; Søreide, Eldar. 2007. Resuscitative emergency thoracotomy in a Scandinavian trauma hospital - is it justified? Injury. 38: 34-42. doi: 10.1016/j.injury.2006.06.125
  • Janssen, Emiel A.M.; van Diest, Paul J; Søiland, Håvard; Gudlaugson, Einar; Nysted, Arne; Voorhorst, Feja J.; Vermorken, Jan B.; Søreide, Jon Arne; Baak, Johannes Peter A. 2006. Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years. Cellular Oncology. 28: 295-303.
  • Søreide, Jon Arne; Søreide, Kjetil; Kørner, Hartwig; Søiland, Håvard; Greve, Ole Jacob; Gudlaugsson, Einar. 2006. Benign peritoneal cystic mesothelioma. World Journal of Surgery. 30: 560-566. doi: 10.1007/s00268-005-0639-z
  • Søreide, Kjetil; Janssen, Emiel A.M.; Søiland, Håvard; Kørner, Hartwig; Baak, Johannes Peter A. 2006. Microsatellite instability in colorectal cancer. British Journal of Surgery. 93: 395-406. doi: 10.1002/bjs.5328
  • Søreide, Kjetil; Søiland, Håvard; Kørner, Hartwig; Haga, Harald; Søreide, Jon Arne. 2005. Acute pancreatitis in a young girl with the Netherton syndrome. Journal of Pediatric Surgery. 40: 69-72. doi: 10.1016/j.jpedsurg.2005.07.058
Reports and theses
  • Søiland, Håvard. 2008. Apolipoprotein D and Androgen Receptor in Operable Breast Cancer. 226 pages.

More information in national current research information system (CRIStin)